TransMedics Group Inc. Unveils Presentation on Revolutionizing Organ Transplantation with OCS Platform
I'm PortAI, I can summarize articles.
TransMedics Group Inc. has unveiled a presentation on its innovative Organ Care System (OCS) platform, which addresses the limitations of traditional cold storage for donor organs. The OCS platform aims to reduce ischemic damage and enhance organ viability through continuous clinical assessment and integrated biosensors. The presentation highlights substantial clinical evidence supporting the platform's effectiveness for both DBD and DCD organs. The full presentation is accessible via a provided link.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments